Understanding the costs of drug-related actions is an important aspect of drug policy.
There were no associated comprehensive budgets for the Norwegian National Action Plan on Alcohol and Drugs (2007-12); however, the authorities estimated that, between 2007 and 2011, approximately EUR 125 million of public funds was allocated to drug-related activities. Neither the method nor the data used to calculate this estimate could be assessed.
In the action plan for 2016-20, the drug and alcohol fields were allocated a budget of EUR 266.7 million (NOK 2.4 billion). An additional budget of EUR 20.5 million (NOK 185 million) for interdisciplinary specialised treatment for problem drug and alcohol use was foreseen in 2016; and expenses for specialist health services were estimated to be EUR 558.83 million (NOK 5 193 billion) in 2015. In addition, the (partial) financing of various public institutions in the alcohol and drugs field amounted to approximately EUR 30.8 million (NOK 276 million) in 2015.
Over the last decade, because of the decentralised health and social service systems in Norway, a large number of authorities, institutions and organisations have been involved in drug policy funding. The nature of the funding system and the lack of consolidated data mean that reporting on the total size and trends in drug-related public expenditure in Norway is not possible.